Feasibility study: Human leukocytes antigen (HLA) proteins as novel immunomodulatory agents for cancer treatment: MIP: none

Font Standard Bold
Login

Project search
Actual Project
Recent projects
Graphics
Login

Research unit

INNOSUISSE

Project number

17225.1;4 PFLS-LS

Project title

Feasibility study: Human leukocytes antigen (HLA) proteins as novel immunomodulatory agents for cancer treatment: MIP: none

Basic data
Texts
Participants

Texts for this project

	German	French	Italian	English
Short description	-	-	-
Abstract	-	-	-

Inserted texts

Category	Text
Short description (English)	Feasibility study: Human leukocytes antigen (HLA) proteins as novel immunomodulatory agents for cancer treatment
Abstract (English)	We describe the development of a novel class of immunomodulating drugs derived from the human leukocyte family (HLA). We demonstrate that HLA molecules modulate the immune system by boosting anti-tumor immunity. Our focus on the discovery and development of novel immunomodulating drugs for cancer treatment opens other potential therapeutic applications so as infectious diseases and immunodeficiency disorders.

Category

Text

Short description
(English)

Feasibility study: Human leukocytes antigen (HLA) proteins as novel immunomodulatory agents for cancer treatment

Abstract
(English)

We describe the development of a novel class of immunomodulating drugs derived from the human leukocyte family (HLA). We demonstrate that HLA molecules modulate the immune system by boosting anti-tumor immunity. Our focus on the discovery and development of novel immunomodulating drugs for cancer treatment opens other potential therapeutic applications so as infectious diseases and immunodeficiency disorders.